Origin and maturation of the pulmonary lymphatic endothelium by Norman Jr., Timothy Alfred
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2019
















TIMOTHY ALFRED NORMAN JR. 
B.S., Biology, University of North Carolina at Wilmington, 2005 




Submitted in partial fulfillment of the  
Requirements for the degree of 



















                
 
                ©  2019 by 
                                                                TIMOTHY ALFRED NORMAN JR. 









First Reader       _______________________________________________ 
       Alan Fine, M.D. 





Second Reader  _______________________________________________ 
       Laertis Ikonomou, Ph.D. 
       Assistant Professor of Medicine 
 
  iv 
DEDICATION 
This is for the innumerable individuals who have helped me along the way. 
 
First, for my mother, for her encouragement, support, and sage advice to, “Grow 
up, go to college and get the hell out of this town and see the world.”  I’m still 
working on the growing up part. All of my achievements are a testament of her 
love, sacrifice, and grit, which she instilled in me early on. For that, I am eternally 
grateful.  For my grandmother, Momma Linda, whose love of life and passion for 
nature kindled a creative, curious fire in me from a young age.   
 
Finally, for my two kids, Finley and Harper, and my wife, Laura Neubauer-
Norman for her undying love, eternal optimism, for her financial, emotional and 






  v 
ACKNOWLEDGMENTS 
First and foremost, I have to acknowledge my God and Savior in Christ Jesus, for 
all things, even the very breath in my lungs.  I hope the time and talents that I 
have vested in this work may be used to benefit Him and His creation.  Amen! 
 
For Alan Fine, for believing in me, for his patience and his willingness to debate 
and argue with me, which was always borne out of a true passion for science.  
For trusting me and letting me choose this project, which is an opportunity that 
few other graduate students are entrusted with. Thank you. 
 
To the many friends I have made during my PhD studies, thank you for helping 
take the sting out of defeat, for genuinely sharing in my small victories and for 
always keeping me grounded and hopeful.  Of these, namely Alex Barron, Dan 
Taub, Anukul Shenoy, Greg Wasserman and Aleks Szymaniak have been 
especially great friends. 
 
“May joy and peace surround you, contentment latch your door, and happiness 




  vi 
ORIGIN AND MATURATION OF THE PULMONARY LYMPHATIC 
ENDOTHELIUM 
 
TIMOTHY ALFRED NORMAN JR. 
 
 
Boston University School of Medicine, 2019 
Major Professor:  Alan Fine, M.D., Professor of Medicine 
 
ABSTRACT 
 The lymphatic vasculature is composed of lymphatic endothelial cells 
(LECs) that coalesce into a branched hierarchy of small capillaries and larger 
collecting vessels that regulate interstitial fluids, lipid uptake and immunity. Few 
studies have focused on pulmonary lymphatic system.  To fill these critical 
knowledge gaps, we interrogated the fetal maturation program of lymphatic 
endothelium, and we provide evidence that CSF1R-lineage progenitors 
contribute to LECs in the lung during a temporally defined period in early 
postnatal life. 
 The pulmonary lymphatic system is required for fluid clearance and air 
breathing at birth, suggesting a prenatal maturation program.  To interrogate this, 
we developed a cell sorting strategy to enrich pulmonary LECs by their unique 
cell surface immunophenotype (CD45-, EPCAM-, CD31+, VEGFR3+, PDPN+, 
LYVE1+) for transcriptional profiling. These experiments highlighted the 
coordinate down-regulation of genes involved in “cell cycle”, and “mRNA 
 
  vii 
processing” along with coordinate upregulation of “complement/coagulation 
cascade”, “lipid metabolism”, and “angiogenesis” genes from embryonic day 
E16.5 to E18.5.  The most significantly enriched gene set corresponded to the 
“interferon-alpha/beta signaling” pathway which was confirmed with qRT-PCR 
and in-situ hybridization. These data provide the first description of the 
transcriptional landscape of fetal pulmonary LEC maturation. 
 During development, all LECs are thought to originate from embryonic 
veins, however multiple studies have suggested a myeloid origin for a subset of 
LECs.  A relationship between myeloid cells and the pulmonary LECs has not 
been elucidated.  Here, we used myeloid-specific inducible CSF1R-CreERtdTomato 
lineage tracing mice and identified rare, single cells that co-expressed CSF1R- 
CreERtdTomato and Prox1, the master lymphatic regulator, in the postnatal day 3 
lung.  This process was temporally restricted to the early postnatal period.  
Lineage tracing with additional myeloid-Cre mice (CSF1R-iCre and CX3CR1-Cre) 
also showed contribution to postnatal LECs.  To determine the biological 
significance of CSF1R-derived LECs to postnatal lung biology, we performed 
conditional Prox1 loss of function experiments. CSF1R-CreER mediated deletion 
of Prox1 resulted in lymphatic hypoplasia, edematous foci and clotting.  These 
findings suggest that early postnatal CSF1R+ progenitors contribute to the 
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The Lymphatic System 
A better understanding of the cellular and molecular mechanisms involved in the 
establishment of a functional lymphatic system is required for life.  Lymphatics 
are required for interstitial fluid homeostasis and immunity.  Lymphangiogenesis, 
the growth of lymphatic vessels, is implicated in numerous pathological 
conditions such inflammation and cancer metastasis.  Defective 
lymphangiogenesis is associated with immune impairment, diabetes and obesity; 
and lymphatic dysfunction results chronic tissue swelling known as lymphedema.   
The lymphatic system has been conserved across teleost fish, amphibians, 
reptiles and mammals and is essential for vertebrate life.  Lymphatic diseases, 
whether congenital or acquired, result in devastating pathologies in both 
developed and undeveloped countries.  Lymphedema is a highly prevalent, 
chronic lymphatic disease that results in painful, disfiguring tissue swelling and 
affects 200,000 people in the United States every year.  In the developing world, 
the scourge of lymphatic filariasis remains a leading cause of permanent 
disability worldwide.  The disease is caused by a helminth whose life cycle 
depends on and ultimately disrupts the lymphatic system leading to severe 




pulmonary diseases such as asthma, interstitial pulmonary fibrosis, sarcoidosis, 
tuberculosis and lymphangioleiomyomatosis and cancer metastasis.   
 
The Lung 
The pulmonary system is fundamental to air breathing.  In addition to its central 
role in gas exchange, the lung also contributes to organismal health and 
homeostasis through acid-base regulation, blood pressure regulation, barrier 
defense and immuno-protection.   
Unfortunately, respiratory diseases and infections inflict devastating morbidities 
and account for more than 14% of all human deaths worldwide.  With recent 
breakthroughs in immunotherapy, genome editing and lung regeneration, 
promising treatment options may soon be realized.  However, a more robust 
understanding of the basic lung biology will undoubtedly inform future 
approaches to combat lung diseases and alleviate human suffering.  
 
Pulmonary LECs are one of 40 different cell types in the lung but they have been 
grossly understudied.  The major thrust of this research is to elucidate the cellular 
and molecular mechanisms regarding the origins and maturation of the lymphatic 






Development of the Mammalian Lung 
The mammalian lung is an extraordinarily complex three-dimensional structure 
indispensable for terrestrial life and air breathing.  Lung function depends on 
coordination of multiple tissue types to organize and establish the inverted tree of 
tubular structures. These tubular systems are composed of the airways, blood 
vessels and lymphatic vessels.   
 
During gestation, the fetal lung is filled with amniotic fluid and the fetus is reliant 
upon placental gas exchange while it resides in an aqueous, intrauterine 
environment.  At birth, the neonatal transition to extra-uterine life is accompanied 
by spontaneous initiation of air breathing and a switch to pulmonary gas 
exchange.  This requires the clearance of fetal lung fluids prior to air breathing, a 
task that the pulmonary lymphatic system is uniquely able to accomplish.  
Furthermore, an intact lymphatic system is required for postnatal survival in order 
to generate adaptive immune memory to exposures that occur during the 
inhalation of non-sterile air each day. 
 
Mature lungs can be subdivided into three anatomically distinct regions.  These 
regions comprise the large proximal airways that decrease in caliber distally, 




gas exchange occurs (Fine, 2009).  Before we can understand the complexities 
of the adult lung structure and function, we must first understand the molecular 
embryology and the various stages identified throughout lung development.   
 
Lung development progresses through five histologic stages: embryonic, 
pseudoglandular, canalicular, saccular, and alveolarization stages (Warburton et 
al., 2010). Lung organogenesis begins during the “embryonic stage” at 
embryonic day 9 (E9-E9.5) in the mouse and around weeks 3-4 of human 
gestation.  At this time, the lung primordium is specified and evaginates from the 
anterior foregut.  The “pseudoglandular” stage spans from weeks 5-17 in humans 
and from E9.5-E16.5 in the mouse.  During this period, simple, cuboidal epithelial 
tubes undergo branching morphogenesis and have an “exocrine gland-like” 
appearance, hence the name.  The “canalicular stage” (15-24 weeks in humans 
and from E16.6-E17.5 in mice) involves growth of airways in length and diameter, 
exuberant angiogenesis and vascularization.  During this stage, terminal 
bronchioles are subdivided into alveolar ducts, and cellular differentiation into 
squamous and cuboidal epithelial cell types.   The major event occurring during 
the terminal “saccular stage” (week 24-late fetal period in humans and E17.5 to 
PND5 in mice) involves thinning of the mesenchymal interstitium and primary 
septum formation.  Also during this stage, alveolar epithelial cells (AECs) 
become more differentiated as noted by the presence of lamellar bodies in the 




“alveolarization stage” of murine lung development occurs postnatally between 
PND 5-30.  In contrast, human alveolarization begins very late in fetal 
development to late childhood (~8 years) and is characterized by further 
septation of terminal saccules into alveoli where the gas exchange surface area 
is formed. 
 
During this first embryonic stage, signals such as Shh, Wnt2/2b, Bmp4/TGF-beta 
and retinoic acid induce Nkx2.1 expression in the ventral foregut endoderm 
(Herriges and Morrisey, 2014; Rankin et al., 2016).  These Nkx2.1+ progenitors 
will give rise to the future lung epithelium, although Nkx2.1 activity is not required 
for lung specification (Minoo et al., 1995; Yuan et al., 2000). Pathologic 
specimens of human lungs born with Nkx2.1 deficiency syndrome resemble 
Nkx2.1 knockout mouse lungs that are characterized by hypoplasia, branching 
morphogenesis defects and hyaline deposition (Galambos et al., 2010; Yuan et 
al., 2000). After the Nkx2.1+ lung progenitors are specified, Tbx4 activation of 
Fgf10 expression in the surrounding mesenchyme induces lung buds to emerge 
bilaterally from the ventral anterior foregut (Warburton et al., 2010; Zhang et al., 
2013).  Thereafter, the nascent lung buds bifurcate and undergo iterative 
branching morphogenesis.  These branching zones are established by 
exquisitely regulated signals that pattern proximo-distal domains of the 
pulmonary epithelium (Metzger et al., 2008).   The various cellular constituents 




functions. Cells of the proximal domain (trachea and bronchi) will acquire club, 
secretory, ciliated, pulmonary neuroendocrine or basal cell fates.  Cells of the 
distal domain will be specified to become AEC1s and AEC2s in the alveolar 
compartment.  
 
In the proximal airway epithelium, club cells express CC10/CCSP/SCGB1A1 and 
SCGB3A2 and have been shown to act as a self-renewing progenitor in small 
postnatal bronchioles but as long-term, transit-amplifying progenitors for 
secretory and ciliated cells in the trachea following injury (Fine, 2009).  Ciliated 
cells express FOXJ1 and TUBA1B and are terminally differentiated and regulate 
mucociliary clearance (Rawlins and Hogan, 2008).  Pulmonary neuroendocrine 
cells (PNECs) are innervated at their basal domain and their cytoplasm contains 
dense, secretory granules stored with bioactive amines and neuropeptides. 
PNECs are found in the trachea and at branch points of bifurcating airways. 
Furthermore, PNECs express CGRP, MASH1/ASCL1, as well as PROX1, and 
release their granular contents to regulate pulmonary blood flow, bronchiolar 
tone, immune status and the local stem cell niche (Song et al., 2012). 
 
Stem cells are defined by their ability to continuously propagate via self-renewal 
as well as their ability to differentiation into specialized, differentiated daughter 
cells.  Basal cells are the stem cell population in the tracheobronchial region of 




mice.  Basal cells express NGFR, KRT5, and P63, and are capable of self-
renewal and differentiation into club cells, ciliated and secretory cells.  Certain 
inherited or acquired mutations or environmental exposures that damage basal 
cells may lead to squamous metaplasia in basal cells which is a pre-cancerous 
lesion that could transitional to carcinoma in situ (Thiberville et al., 1995).  
 
AEC2s are the lung stem cell in the distal alveolar compartment (Barkauskas et 
al., 2013).  These cells contain multi-vesicular lamellar bodies stored with 
SFTPA, SFTPB and SFTPC in their cytoplasm.  Surfactant secretion from AEC2 
increases lung compliance and reduces surface tension to maintain a patent 
lumen for gas exchange.  During development and after injury, AEC2s serve as 
the progenitor for additional AEC2s as well as AEC1s.  AEC1s are the flattest cell 
in the body; uniquely specialized to establish a thin diffusion barrier between air 
and blood for gas exchange. 
 
Though significant differences in lung structures exists (Rock et al., 2010), the 
coordinate regulation of lung ontogeny, branching morphogenesis, and 
alveolarization appears to be highly conserved across air-breathing evolution 




The Ontogeny of Air Breathing 
Evolution of the lung was a major phylogenetic milestone that enabled our 
tetrapod ancestors to transition from the hypoxic, aqueous environment of the 
seas to an oxygen-rich terrestrial existence. The precursor to all vertebrates 
existed ~500 Mya during the Cambrian period and was likely the jawless, soft-
body fish Metaspriggina that used external gills for gas exchange (Morris and 
Caron, 2014).  Thus, the air-breathing respiratory apparati of extant tetrapods 
has its origins in gill breathing. The first highly primitive lungs likely appeared in 
the last common ancestor of two fish clades:  the Actinopterygii (ray-finned) and 
Sarcopterygii (lobe-finned) (Amemiya et al., 2013; Hsia et al., 2013). During the 
Cretaceous period (145-85 Mya), the Actinopterygiian bichir fish (Polypterus) 
appeared with a pair of simplistic lungs.  These lungs enable the bichir fish to 
breath air but they lack overall complexity such as alveolar septation that is 
required for maximal gas exchange surface area, typical of higher order 
vertebrate lungs.   
 
Survival of the Sarcopterygiian lungfish spans from  ~300 Mya to present.  This 
fish is widely regarded as the common ancestor to all tetrapods (this includes 
mice and humans).  This timing is remarkable and provides evidence that the 
lung may have preceded the swim-bladder during evolutionary time (Hsia et al., 
2013)!  Scanning electron microscopy studies indicate that the airways of 




gas exchange surface area. Furthermore, alveoli in the lungfish are composed of 
two distinct cell types: type 2-like cells with a granular, cuboidal and ciliated 
morphology, and type 1-like cells that are smooth and flattened for gas diffusion 
across the air-blood interface (Hsia et al., 2013; Maina, 1987).  Overall, the lungs 
in the lungfish are strikingly similar to the cellular constituents of mammalian 
lungs.   
 
Placental mammals evolved 160 Mya (Luo et al., 2011). Subsequent evolution of 
the rodents and divergence of the mouse (Mus) and rat (Rattus) lineage occurred 
33 Mya.  Based on genetic homology to humans, these rodent groups have been 
instrumental to medical and healthcare research as mammalian models of 
human development and disease. 
 
Lymphatic Discoveries Throughout History 
Hippocrates (460-370 BC) is usually credited for the initial discovery of the 
lymphatic system carrying “white blood” around 400 B.C.  After Galen described 
chyle transport in gut lymphatic vessels, more than a thousand years passed 
before Gaspare Asseli described “milky veins” in his treatise “De łactibus sive 
łacteis venis”.  Published in 1627, Asseli’s description on the movement of lymph 
preceded William Harvey’s 1628 masterpiece De Mota Coraïs, which explained 




understanding of lymph as an albuminous ultrafiltrate of plasma and the forces 
that drive capillary resorption of water and solutes. 
In 1902, Florence R. Sabin, M.D., published the first work on lymphatic 
development using vital dye injections to ascertain the embryologic origins of the 
lymphatic system in fetal pigs.  Sabin’s discovery that the lymphatic endothelium 
is specified in and emerges from the cardinal veins has served as the foundation 
for the field of lymphatic development for nearly 120 years (Sabin, 1902)!  
 
Lymphatic System: Development and Pathogenesis 
Diverse bodily functions such as fluid homeostasis, immune responses, blood 
pressure regulation and fat absorption and reverse cholesterol transport require 
an intact lymphatic system (Alitalo et al., 2005; Tammela and Alitalo, 2010).   
 
Development of the lymphatic system, begins during gestational week 5 in 
humans and at E9.5 in mice, and is absolutely required for life (Escobedo and 
Oliver, 2016; Wigle and Oliver, 1999).  Our understanding of lymphatic biology 
has advanced in the last 25 years with the identification of genes expressed by 
LECs that distinguish them from blood endothelial cells.  These molecules 
include PROX1, LYVE1, VEGFR3 and PDPN.  The precise mechanisms of 
lymphatic specification during embryogenesis is still not clear, however Prox1 




have been shown to be essential transcription factors for Prox1 induction and 
lymphatic specification (Srinivasan et al., 2010; You et al., 2005).  Prox1 leads to 
upregulation of VEGFR3 in the LEC progenitors that migrate out of embryonic 
venous lumens in response to VEGF-C gradients secreted by the surrounding 
mesenchyme (Srinivasan et al., 2014; Yang and Oliver, 2014).  After the 
embryonic specification (due to the transdifferentiation of venous endothelium), 
the process of lymphatic growth is thought to proceed via lymphangiogenesis, or 
expansion of the lymphatic vasculature from pre-existing lymphatic vessels 
through proliferation (Bos et al., 2011; Bruyere et al., 2008).  Nevertheless, 
recent work has shown that the lymphatic vasculature of the heart, skin, 
mesentery and brain develop via organ-specific mechanisms and that all LECs 
may not necessarily arise from pre-existing LECs (Kerjaschki et al., 2006; Klotz 
et al., 2015; Martinez-Corral et al., 2015; Maruyama et al., 2005; Nicenboim et 
al., 2015; Pichol-Thievend et al., 2018; Religa et al., 2005; Stanczuk et al., 2015). 
 
The lymphatic system is directly implicated as a driver of several diseases such 
as lymphedema, lymphangioleiomyomatosis (LAM), Gorham-Stout disease, 
Kaposi sarcoma, as well as helminthic infections (Alitalo, 2011; El-Chemaly et al., 
2008; Tammela and Alitalo, 2010).  Other diseases and syndromes may arise 
from mutations that disrupt genes critical to lymphatic formation or function.  For 
instance, Hennekam syndrome is caused by mutations in Ccbe1 that lead to 




extremity, facial dysmorphism and cognitive impairment.  Milroy syndrome arises 
from mutations in Vegfr3 and affected patients have a clinical presentation of 
severe lymphedema usually confined to the extremities.  Foxc2 mutations lead to 
Lymphedema-Distichiasis Syndrome (LDS) and Meige Disease (lymphedema 
without distichiasis).  These two conditions are characterized by severe 
lymphedema of the lower extremities and present around the time of puberty.  
Gata2 mutations result in myelodysplastic syndromes and acute myeloid 
leukemia (MDS/AML) but also result in lymphatic dysplasia and lymphedema 
(Kazenwadel et al., 2012; Spinner et al., 2014).  
 
The central focus of this work addresses the lymphatic system, a key cell type in 
the lung that has received little attention from both researchers and clinicians 
(Rockson, 2017).  More specifically, this work focuses on the origin(s) of the 
lymphatic endothelium in the lung, how they mature and their function in the 
respiratory system.  The present work consists of two independent chapters that 
advance our understanding of the pulmonary lymphatic system specifically in the 
perinatal period – a critical period marked by dynamic structural and functional 
changes in the mammalian lung.  Chapter 1 titled: “TRANSCRIPTIONAL 
LANDSCAPE OF PULMONARY LYMPHATIC ENDOTHELIAL CELLS DURING 
FETAL GESTATION” forms a manuscript that is currently in revision.  This 
chapter reveals a new method to isolate fetal LECs from the lung and presents 




Chapter 2 is titled: “LYMPHATIC ENDOTHELIUM ARISE FROM A CSF1R+ 
PROGENITOR IN THE POSTNATAL LUNG” and is currently in preparation for 
submission.  Chapter 2 addresses the origins of LECs and identifies a novel 
progenitor for the pulmonary lymphatic endothelium specifically in the early 
postnatal period.   In each of these chapters, the process of lymphangiogenesis 






TRANSCRIPTIONAL LANDSCAPE OF PULMONARY LYMPHATIC 
ENDOTHELIAL CELLS DURING FETAL GESTATION 
 
Disclaimer:  Transcriptional landscape of pulmonary lymphatic endothelial cells 





The genetic programs responsible for pulmonary lymphatic maturation prior to 
birth are not known.  To address this gap in knowledge, we developed a novel 
cell sorting strategy to collect fetal pulmonary lymphatic endothelial cells (PLECs) 
for global transcriptional profiling.  We identified PLECs based on their unique 
cell surface immunophenotype (CD31+/Vegfr3+/Lyve1+/Pdpn+) and isolated 
them from murine lungs during late gestation (E16.5, E17.5, E18.5).  Gene 
expression profiling was performed using whole-genome microarrays, and 1,281 
genes were significantly differentially expressed with respect to time (FDR q < 
0.05) and grouped into six clusters.  Two clusters containing a total of 493 genes 
strongly upregulated at E18.5 were significantly enriched in genes with functional 
annotations corresponding to innate immune response, positive regulation of 
angiogenesis, complement & coagulation cascade, ECM/cell-adhesion, and lipid 




coordinately upregulated during late gestation, the strongest of which was the 
type-I IFN-α/β signaling pathway.  Upregulation of canonical interferon target 
genes was confirmed by qRT-PCR and in situ hybridization in E18.5 PLECs. We 
also identified transcriptional events consistent with a prenatal PLEC maturation 
program.  This PLEC-specific program included individual genes (Ch25h, Itpkc, 
Pcdhac2 and S1pr3) as well as a set of chemokines and genes containing an 
NF-κB binding site in their promoter.  Overall, this work reveals transcriptional 
insights into the genes, signaling pathways and biological processes associated 
with pulmonary lymphatic maturation in the fetal lung. 
 
INTRODUCTION 
The earliest LEC progenitors express Prox1, a required lymphatic transcription 
factor, in a distinct subset of anterior cardinal venous endothelial cells at ~E9.5 in 
the mouse (Sabin, 1902; Srinivasan et al., 2007; Tammela and Alitalo, 2010; 
Wigle and Oliver, 1999) though several groups have suggested additional non-
venous origins (Buttler et al., 2006; Kerjaschki et al., 2006; Klotz et al., 2015; 
Martinez-Corral et al., 2015; Maruyama et al., 2005; Nicenboim et al., 2015; 
Pichol-Thievend et al., 2018). Vegfr3 activation by Vegf-C induces Prox1+ LEC 
progenitors to emerge from cardinal and intersomitic veins to form the jugular 
lymph sacs and subsequently migrate into peripheral tissues (Hagerling et al., 
2013; Kaipainen et al., 1995; Karkkainen et al., 2004; Srinivasan et al., 2014; 




lung parenchyma beginning around E10.5-E11.5 prior to lumen formation 
(Kulkarni et al., 2011). 
 
During late gestation, the lymphatic vasculature undergoes dynamic structural 
changes as they gain the capacity to transport cells and macromolecules.  This 
provides evidence that pulmonary lymphatics undergo functional maturation 
prenatally (Baluk et al., 2007; Jakus et al., 2014; Yao and McDonald, 2014).  This 
process may be part of a broader, generalized paradigm whereby cellular 
maturation in the late fetal lung precedes the transition to air breathing.  
Examples include AEC2 surfactant biosynthesis, macrophage-mediated 
surfactant catabolism, alveolar type I cell flattening, as well as vascular and 
interstitial remodeling (Gao and Raj, 2010; Ghosh et al., 2011; Morgan, 1971; Xu 
et al., 2012).  Accordingly, the complex pathology of the premature lung likely 
reflects maturational defects in multiple cell types and signaling events. 
 
For survival after birth, a mature pulmonary lymphatic system is necessary for 
proper immune surveillance and lung fluid homeostasis. In this context, two 
groups have shown that fetal lymphatic ablation results in lung fluid retention and 
respiratory distress at birth (Jakus et al., 2014; Kulkarni et al., 2011) though the 
effect of lymphatic ablation on immune function was not examined. Notably, 
alterations in lymphatic structure and function have been implicated in lung 




dysplasia, pulmonary lymphangiectasia, congenital chylothorax and asthma (El-
Chemaly et al., 2008). 
 
Despite the fundamental importance of lymphatics for optimal lung function and 
their implication in respiratory pathologies, little is known regarding the 
transcriptional mechanisms associated with pulmonary lymphatic maturation prior 
to birth.  To address this gap in knowledge, we established a cell sorting method 
to isolate CD45-/Epcam-/CD31+/Vegfr3+/Lyve1+/Pdpn+ primary PLECs from 
fetal murine lungs for transcriptional profiling using microarrays.   
 
Here, we identified differentially expressed genes and pathways involved in 
vascular development, complement and coagulation cascades, lipid biosynthesis 
and metabolism and the innate immune response.  The type I interferon (IFN-I) 
signaling pathway was the gene set with the greatest coordinate upregulation 
from E16.5 to E18.5, which was confirmed by qPCR and in situ hybridization.  
Furthermore, NF-kB target genes, chemokines and additional genes were 
upregulated specifically in late-gestation PLECs.  Together, these data provide 
novel insights into the transcriptional mechanisms, biological processes and key 
signaling events associated with lymphatic maturation in the fetal lung, a critical 




MATERIALS AND METHODS 
Mice and tissue processing 
Our protocol was approved under Boston University IACUC Protocol# 14419. 
Timed pregnant mice (C57BL/6NCrl) were ordered from Charles River Labs and 
cared for in the BU Animal Science Center on a 12-hour light:dark cycle with 
access to food and water ad libitum. Time pregnant dams and fetal offspring 
were ethically euthanized under deep isoflurane anesthesia followed by 
harvesting of lung tissues from E16.5, E17.5 and E18.5 mice for PLEC isolation. 
On gestational days E16.5 and E18.5, fetuses from anesthetized pregnant mice 
were removed from the gravid uterus prior to dissection of the lungs and heart en 
bloc in ice-cold Hank’s Buffered Saline solution (HBSS). Tissues were fixed in 
fresh 4% paraformaldehyde (Ted Pella) at 4°C overnight.  Specimens were 
washed in PBS (pH 7.4), dehydrated through 50%, 70%, 85%, 100% ethanols 
and 100% xylene (30 min/each) solutions. Tissues were then incubated at 60°C 
in 1:1 xylene:paraffin wax (1 hr) , 100% paraffin (2 hr) and then embedded in 
paraffin molds at 4°C.  E16.5 and E18.5 paraffin sections were mounted on 
Superfrost Plus glass slides (Fisher Scientific).    
 
Immunostaining and confocal imaging 
Prior to immunostaining, sections were de-paraffinized, rehydrated and 




3300, Vector Labs), washed in PBS and blocked for 1 hr in 0.1%Tween-20 in 
PBS and 5% normal donkey serum.  Antibodies used were: goat anti-Prox1 
(R&D, AF2727), rat anti-Vegfr3 (Novus, AFL4), rat anti-Lyve1 (Novus, ALY7), 
rabbit anti-CD31 (Abcam, ab28364) and Syrian hamster anti-Pdpn (DSHB, 
8.1.1). Alexa Fluor conjugated secondary antibodies used were: donkey anti-goat 
AlexaFluor647, donkey anti-rat AlexaFluor488, donkey anti-rat AlexaFluor594, 
donkey anti-rabbit AlexaFluor-594 (all from Invitrogen), and rabbit anti-Syrian 
hamster AlexaFluor-488 (Jackson Immunologics).  Maximum intensity projections 
of 8-10 µm z-stack images were acquired on a Zeiss LSM 710 NLO confocal 
microscope using the smart setup tool in sequential scanning mode.   
 
In situ hybridization 
E16.5 and E18.5 fetal lungs were fixed in 4% paraformaldehyde overnight, 
processed, and paraffin embedded according to manufacturer’s 
recommendations. Antigen retrieval was carried out on 8 µm lung sections (n=3 
mice/time point) via the microwave method. All reagents for peroxidase 
quenching, protease digestion, washing, hybridization and transcript detection for 
Ifit1 (ACDBio, cat# 500071) were purchased from the manufacturer and used 
according to the recommendations for the RNA Scope method (ACDBio). In 
order to identify PLECs, sections were concomitantly blocked and 





Fluorescence activated cell sorting and RNA extraction 
Timed pregnant C57BL/6NCrl dams (Charles River Labs) at embryonic days 
E16.5, E17.5, E18.5 were euthanized by cervical dislocation under isoflurane 
anesthesia. Samples (n=3) for each time point consisted of pooled embryonic 
lungs from two litters.  Embryonic lungs were dissected in ice-cold HBSS, minced 
and enzymatically digested in a 37 °C shaker for 1 hr at 200 rpm in 5 mL HBSS 
containing 5 µg/mL collagenase II (Worthington), 2.5 mM CaCl2, 10 U/mL DNase 
I followed by gentle trituration every 15 mins.  After 1 hr, digests were inactivated 
with addition of two volumes of FACS buffer (2% FBS/5 mM EDTA in HBSS 
without Ca2+ or Mg2+), centrifuged at 500g x 7 mins at 4°C, resuspended in 5 mL 
FACS buffer, passed through 70 µm and 40 µm cell strainers, and then 
centrifuged at 500 g x 7 mins at 4°C.  The whole lung cell pellets were gently 
disrupted in 2 mL Hybri-Max RBC lysis buffer (Sigma-Aldrich) for 1 min, diluted 
with 10 mL FACS buffer and centrifuged at 500 g x 7 mins at 4°C. Pellets were 
resuspended in 1 mL FACS buffer, blocked with CD16/32 antibodies (1:100) for 
10 mins, and then immunostained with the following antibodies: CD45-eFluor450 
(1:500), Epcam-eFluor450 (1:50), Pdpn/8.1.1-PE (1:100), Lyve1-eFluor660 
(1:100), CD31-PerCP710 (1:100) (all from EBioscience), and Vegfr3-AF488 
(1:50) (Novus, AFL4).  Dead cells were discriminated using 1:250 dilution of 




for 30 min on ice in the dark before washing with 1 mL FACS buffer, 
centrifugation and resuspension in 500 µL FACS buffer.  Cell sorting experiments 
were performed on a FACS Aria SORP and analyzed with FlowJo v10.2. All 
sorted cell populations were collected directly into RNA lysis buffer.  RNA was 
extracted using the miRNEasy kit (Qiagen) and cDNA was generated using 
Superscript III reverse transcriptase (ThermoFisher).  Samples with an RNA 
Integrity Number (RIN) ≥ 7.5 were retained in the analysis. 
 
Microarray analysis: PLECs 
Mouse Gene 2.0 ST CEL files were normalized to produce log2-transformed 
gene-level expression values using the implementation of the Robust Multiarray 
Average (RMA) in the affy R package (version 1.36.1) and an Entrez Gene-
specific probeset mapping (version 17.0.0) from the Molecular and Behavioral 
Neuroscience Institute at the University of Michigan(the "Brainarray" group). 
Array quality was assessed by computing Relative Log Expression (RLE) and 
Normalized Unscaled Standard Error (NUSE) using the affyPLM R package 
(version 1.34.0); all samples had median RLE and NUSE values below 0.1 and 
1.05, respectively.  Principal Component Analysis (PCA) was performed using 
the prcomp R function with expression values z-normalized across all samples 
(set to a mean of zero and a standard deviation of one). Differential expression 




implemented in the limma R package (version 3.14.4), i.e., creating simple linear 
models with lmFit, followed by empirical Bayesian adjustment with eBayes. 
Correction for multiple hypothesis testing was accomplished using the Benjamini-
Hochberg false discovery rate (FDR). All microarray analyses were performed 
using the R environment for statistical computing (version 2.15.1). The raw and 
processed gene expression data have been deposited in the Gene Expression 
Omnibus (GEO), Series GSE121079. 
Microarray analysis: GSE35485, whole fetal lung 
Mouse Gene 1.0 ST CEL files were obtained from the Gene Expression Omnibus 
(GEO) Series GSE35485, which profiled gene expression in whole lung during 
perinatal maturation.  Analysis was limited to the samples from the E16.5, E17.5, 
and E18.5 timepoints in C57BL/6 animals. Normalization to Entrez-Gene-specific 
expression values, statistical analysis, and GSEA were performed in the same 
manner and with the same software versions and parameters as described 
above for the PLEC microarrays. 
 
Functional annotation 
Mouse Entrez Gene identifiers from each cluster were analyzed using the 
Database for Annotation, Visualization and Integrated Discovery (DAVID, v6.8) 
with the GOTERM_BP_DIRECT collection to identify Gene Ontology (GO) 





Gene Set Enrichment Analysis (GSEA): PLECs 
The Entrez Gene identifiers of the human homologs of all mouse Entrez Genes 
present in the probeset mapping described above (identified using HomoloGene, 
version 68) were ranked according to the t statistic computed between the E16.5 
and E18.5 time points.  The ranked list was limited to only those human genes 
that correspond 1:1 with a mouse homolog, and used to perform pre-ranked 
GSEA (version 2.2.1, default parameters with random seed 1234) using the 
Entrez Gene versions of the Biocarta, KEGG, and Reactome (c2 CP) motif (c3) 




Independent PLEC RNA samples were generated to validate microarray gene 
expression changes and to assess interferon pathway gene expression. Taqman 
qPCR primers used to validate microarray expression data are as follows: Prox1, 
Mm00435969_m1; Vegfr3,  Mm01292604_m1; Lyve1, Mm00475056_m1; Emcn, 
Mm00497495_m1; Gbp4, Mm00657752_m1; Ifit1, Mm00515153_m1;  Irf7, 
Mm00516788_m1;  Socs3, Mm01249143_g1;  Stat1, Mm00439518_m1;  Stat2, 







All statistical analyses utilized a one- or two-tailed Student’s t test as indicated in 





Immunophenotypic analysis and isolation of pulmonary lymphatic 
endothelium 
 
To identify genes, gene networks and signaling pathways associated with LEC 
maturation in the fetal lung, we developed a cell sorting strategy to isolate 
pulmonary LECs (PLECs) for broad-based transcriptomic profiling.  This 
approach is based on the identification of a unique panel of LEC surface markers 
that immuno-colocalized with Prox1, the essential transcription factor required for 
lymphatic development. We found that CD31, Vegfr3, Pdpn, and Lyve1 immuno-
colocalization with Prox1 was only detected in lymphatic vessels in the E16.5 and 
E18.5 lung (Fig 1).  
To isolate LECs by flow cytometry, we analyzed cell fractions in collagenase 
digested lung preparations after staining with the four lymphatic directed 
antibodies that co-localized with Prox1 (Fig 1).  Following exclusion of doublets, 
dead cells, CD45+ hematopoietic cells and Epcam+ lung epithelial cells, we 
identified three major cell populations based on CD31 and Vegfr3 expression 
(Fig 2A) during cell sorting.   The CD31+/Vegfr3+ double positive fraction 
consistently accounted for ~1-2% of total viable cells of which 85-95% also 
expressed the lymphatic markers Lyve1 and Pdpn (Figs 2A & 3, right panels).  A 
subset of CD31+/Vegfr3- cells expressed Lyve1 but not Pdpn, consistent with a 







Figure 1.1.  Immunophenotypic characterization of pulmonary lymphatic 
endothelium at E16.5 and E18.5. (A) Prox1 (white nuclei) in fetal lungs colocalized with 
Vegfr3 (green) and the pan-endothelial marker CD31 (red). (B) Prox1 (white) also 
colocalized with Pdpn (green) and Lyve1 (red) at E16.5 and E18.5. Colocalization of 
Vegfr3, CD31, Pdpn and Lyve1 staining was observed only in pulmonary lymphatic 




Importantly, dual expression of both Pdpn and Lyve1 was only observed in the 
CD31+/Vegfr3+ gate (purple cluster, Fig 2A).  Collectively, these data indicate 
that CD31+/Vegfr3+/Pdpn+/Lyve1+ cells are highly enriched in PLECs. 
To examine this further, we collected mRNA and performed quantitative PCR 
(qPCR) to measure the expression of lymphatic endothelial markers in sorted 
lung fractions.   Compared to other lung cell fractions, the expression of Prox1 
and Flt4/Vegfr3 was significantly higher in sorted CD31+/Vegfr3+/Pdpn+/Lyve1+ 
PLECs at E18.5 (Fig 2B). Importantly, Emcn, a specific marker of blood 
endothelial cells was expressed at significantly higher levels in the 
CD31+/Vegfr3- fraction than in sorted E18.5 PLECs (Fig 2B).  
Furthermore, the expression of Prox1, Flt4/Vegfr3, and Lyve1 was increased 
108-fold, 48-fold, and 8-fold, respectively, in isolated PLECs compared to whole 
E18.5 lung (Fig 3).  Figure 4 shows the sequential gating strategy used to isolate 
CD31+/Vegfr3+/Pdpn+/Lyve1+ PLECs from E16.5, E17.5 and E18.5 fetal lungs. 
Taken together, these data indicate that RNA collected from sorted 
CD31+/Vegfr3+/Pdpn+/Lyve1+ cells can be used to characterize the 
transcriptional programs underlying prenatal PLEC maturation prior to the birth 






Figure 1.2. Isolation and relative purity of sorted CD45-/Epcam-/ 
CD31+/Vegfr3+/Lyve1+/Pdpn+ PLECs.  (A, left) Cell sorting algorithm depicting three 
major cell populations; CD31-/Vegfr3- (grey), CD31+/Vegfr3- (yellow), CD31+/Vegfr3+ 
(purple) observed after excluding CD45+, Epcam+ and dead cells (E18.5 shown). (A, 
right) Expression of Lyve1 and Pdpn in each of the three cell fractions.  (B) RT-qPCR 
measurements of relative Prox1, Flt4/Vegfr3, and Emcn expression in each sorted lung 
fraction. Statistical significance was determined using a two-tailed Student’s t test 






Figure 1.3. Enrichment of lymphatic markers in sorted PLECs.  RT-
qPCR measurement of the lymphatic markers, Prox1, Flt4/Vegfr3, and Lyve1 
in sorted E18.5 PLECs (n=4) versus E18.5 whole lung (n=3). Statistical 









Figure 1.4. Step-wise gating strategy for isolation of PLECs (CD45-
/Epcam-/CD31+/Vegfr3+/Lyve1+/Pdpn+) from late-gestation fetal 
lungs. Representative gate for live, CD45- and Epcam- lung cells is boxed 
(left panels). The gate containing the CD45-/Epcam-/CD31+/Vegfr3+ 
population (boxed, middle panels). (Right panels) The CD45-/Epcam-
/CD31+/Vegfr3+ cellular fraction expressed both Pdpn+ and Lyve1+ 
characteristic of the lymphatic endothelial phenotype across late-gestation 




Temporal-dependent patterns of gene expression in late-gestation PLECs  
We then used whole-genome microarrays to profile gene expression in RNA 
samples isolated from sorted CD31+/Vegfr3+/Lyve1+/Pdpn+ PLECs at E16.5, 
E17.5, and E18.5 days of gestation (n=3 per time point).  Principal Component 
Analysis (PCA) performed across all genes showed that the samples separated 
strongly with respect to time along the first principal component (PC1), which 
explains 22% of total variance (Fig 5A), indicating that many genes are up- or 
down- regulated in a progressive manner from E16.5 to E17.5 to E18.5.  A one-
way analysis of variance (ANOVA) was then performed to identify the 
predominant patterns of coordinate differential expression with respect to time, 
and t tests were performed for each gene between the E16.5 and E18.5 time 
points (Tables 1 and 2).  After excluding genes that were not expressed above 
the median value of at least one array, 1,281 genes, whose expression was 
significantly associated with time (ANOVA, FDR q < 0.05), were partitioned into 
six clusters (Fig. 5B). 
 
Cluster 1 is comprised of 398 genes that are slightly upregulated from E16.5 to 
E17.5 and then strongly upregulated at E18.5.  DAVID analysis indicated that this 
cluster is strongly and significantly enriched in genes associated with the GO 
terms "defense response to virus" (GO:0051607, FDR q = 7.6x10-6), which 
includes Cxcl10, Dhx58, Gpam, Ifit1, Il33, Il6, Isg15, Isg20, Mx2, Oas2, Oasl1, 




to interferon-beta" (GO:0035458, FDR q = 1.7x10-4), which includes Gbp2, Gbp3, 
Gm4951, Ifi203, Ifi47, Ifit1, Igtp, Iigp1, and Irgm1; "response to cytokine" 
(GO:0034097, FDR q = 3.6x10-3), which includes Cd274, Cxcl16, Mapkapk3, 
Ptgs2, Scgb1a1, Serpina3f, Serpina3g, Serpina3n, Skil, and Timp2;  "cell 
adhesion" (GO:0007155, FDR q = 6.7x10-6); "extracellular matrix organization" 
(GO:0030198, FDR q = 1.1x10-5); and "positive regulation of angiogenesis" 
(GO:0045766, FDR q = 1.2x10-4), including Anxa3, C3, Ccbe1, Chi3l1, Ctsh, 
Ecm1, Epha1, Hc, Hspb1, Sema5a, Serpine1, Sphk1, Thbs1, and Vegfa.  This 
cluster also showed nominally significant enrichment for the two overlapping GO 
terms "fatty acid metabolic process" (GO:0006631, p = 9.8x10-3) and "lipid 
metabolic process" (GO:0006629, p = 0.029), which include Abhd5, Apoe, C3, 
Ces1d, Echdc2, Fabp4, Fads3, Gpam, Hsd11b1, Liph, Lpin2, Lpl, Pmvk, Ptgs2, 








Figure 1.5. Temporal-dependent gene expression in fetal PLECs.  
(A) Principal component analysis of E16.5, E17.5, and E18.5 sorted PLECs 
(n=3 per time point). Each axis indicates the fraction of experimental 
variance explained by each principal component (PC). (B) Heatmap of all 
1,281 genes with significant differential expression with respect to time 
(ANOVA FDR q < 0.05).  The number of each cluster is indicated at the 
bottom of the heatmap. Expression values for each gene were z-
normalized to a mean of zero and standard deviation of one across all 
samples in each row; blue, white, and red indicate final z-scores of ≤ -2, 0, 




Cluster 2 contains 95 genes that are upregulated in a gradual manner from E16.5 
to E17.5 and then to E18.5.  These genes are significantly associated with the 
GO terms "positive regulation of antigen processing and presentation of 
endogenous peptide antigen via MHC class I" (GO:0019885, p = 1.8x10-4, FDR q 
= 0.042), including Tap1, Tap2 and Tapbp, and "innate immune response" 
(GO:0045087, p = 1.7x10-3, FDR q = 0.21), including Adar, Ifih1, Irf7, Nod2, Pml, 
Tbkbp1, Trim21, and Trim25.   
 
Cluster 3 encompasses 80 genes with an expression pattern that is abruptly 
down-regulated between E16.5 and E17.5 and remains low at E18.5, including 
genes involved in ubiquitin-dependent protein catabolism (GO:0006511, p = 
0.020): Psma1, Psma4, Ube2c, and Usp11.  Surprisingly, cluster 4, which 
contains only 11 genes with a trough-like pattern of down-regulation at E17.5 
followed by reversion to E16.5 levels at E18.5, was significantly associated with 
the GO term "steroid metabolic process" (GO:0008202, FDR q = 0.066) as it 
contains the genes Hmgcs1, Sc4mol, and Soat1.  However, cluster 5, which 
contains only eight genes that peak at E17.5, was too small to achieve statistical 
significance for any GO terms. 
Cluster 6 contains 689 genes that are progressively down-regulated from E16.5 
to E17.5 and then to E18.5.  This cluster is significantly enriched in genes that 
are involved in mitotic processes and are associated with GO terms such as "cell 




Cdc6/7, Cdc25a/c, Cdk1/2/4, Chek1/2, Mcm4/5, and Mki67; "DNA replication" 
(GO:0006260, p = 6.9 x 10-36), e.g., Cdt1, Chaf1a/b, Gins1/2/4, Lig1, Pole, Polh, 
Prim1/2, Ticrr; and "mRNA processing" (GO:0006397, p = 5.1x10-9), e.g., 
Cpsf2/3, Dhx20/Dhx39, Gemin5, Khsrp, Lsm2, Rbmx, Rnps1, Ttf2, Usp39, 
Wdr33 and Zcchc8. 
Gene Set Enrichment Analysis 
Although the clustering analysis described above identified numerous pathways 
that are significantly overrepresented in gene clusters with temporal-dependent 
expression, some of these results are derived from a relatively small number of 
genes.  To increase statistical power to identify biological pathways that are 
coordinately up- or down-regulated with respect to time, we next performed Gene 
Set Enrichment Analysis (GSEA), ranking the human homologs of all genes 
interrogated by the microarray according to the t statistic computed between the 
early and late time points.  Many gene sets were significantly coordinately 
upregulated from E16.5 to E18.5, including the Reactome "interferon alpha/beta 
signaling" pathway (R-HSA-909733, FDR q < 0.001), which includes Socs3, Irf7, 
Stat1, Stat2, and Usp18 (Fig 6A); the KEGG pathway "complement and 
coagulation cascades" (hsa04610, FDR q = 0.0006), which contains the 
Serping1 and Serpine1, two genes with fibrinolytic and plasminogen inhibitor 




term "regulation of angiogenesis" (GO:0045765, FDR q = 0.012) were enriched 
in genes upregulated at E18.5 (Fig 6C and Table 1).   
Conversely, many gene sets related to mitotic cell cycle were significantly 
coordinately down-regulated from E16.5 to E18.5, including the Reactome "DNA 
replication" pathway (R-HSA-69306, FDR q < 0.001), which includes Mcm5, a 
gene involved in licensing DNA replication (Fig 6D and Table 2).  
 
We selected several canonical interferon-stimulated genes (ISGs) and other 
genes involved in the IFN-I pathway and confirmed their upregulation in 
independently sorted E16.5 and E18.5 PLEC samples by qPCR.  We also 
confirmed down-regulation of Mcm5 in E18.5 PLECs (Fig 7).  Next we used 
single-molecule fluorescent in situ hybridization probes against Ifit1 (interferon-
induced protein with tetratricopeptide repeats 1), a well-established ISG 
significantly upregulated from E16.5 to E18.5 (7.4-fold, FDR q = 3.1x10-3) to 
further confirm that the IFN-I pathway was activated in E18.5 PLECs in vivo (Fig 
8).  This analysis demonstrated increased expression of  Ifit1 in  Vegfr3+ LECs at 
E18.5 versus E16.5.  Combined with the microarray and qPCR analysis, these 
data provide further evidence that PLECs are a target of IFN-I signaling in late 




Fetal PLEC specific maturation profile 
To identify genes and pathways that are unique to PLECs during prenatal 
maturation, we repeated the statistical analysis and GSEA using a publicly 
available microarray dataset (GSE35485) profiling whole fetal lung in C57BL/6 
animals at the same time points, and compared these results with those obtained 
from the PLECs.  The full set of statistical results is provided in Additional File 
S6, and a tabulation of the E18.5 vs E16.5 GSEA results in both the PLECs and 
GSE35485 is provided in Additional File S7.  These analyses demonstrated that 
sets of genes annotated with the GO term "chemokine activity" (GO:0008009) or 
containing an NF-κB binding site (TRANSFAC motif V$NFKAPPAB_01) in their 
promoter were significantly upregulated between E16.5 and E18.5 (FDR q < 
0.25) in PLECs but not in whole lung.  The “chemokine activity” gene set included 
Cxcl1, Cxcl10, Cxcl16, Cxcl2, and Pf4/Cxcl4, and “NF-κB target genes” included 
Prx, Nod2, Ddr1, Tnfrsf1b, Sdc4, Ntn1 and Azin1 (Fig 9A-B).  In addition, the 
expression of several genes listed in Table 1 changed significantly with respect 
to time in PLECs (one-way ANOVA p < 0.05) but not in whole lung, including 
Ch25h, Itpkc, Pcdhac2 and S1pr3, each of which were upregulated from E16.5 to 
E18.5 in a PLEC-specific manner (Fig 9C).  Overall, our results highlight both 








Figure 1.6.  Leading edge heatmaps of selected GSEA results.  The 
expression of the leading edge genes of each GSEA result is shown for (A) 
Reactome "interferon α/β signaling", (B) KEGG "complement and coagulation 
cascades", (C) Gene Ontology "regulation of angiogenesis", and (D) 
Reactome "DNA replication".  Genes (rows) are arranged in descending order 
by the magnitude of the E18.5 vs E16.5 t statistic.  Expression values for each 
gene were z-normalized to a mean of zero and standard deviation of one 
across all samples in each row; blue, white, and red indicate final z-scores of ≤ 





	 FC	 pVAL	 FDR	 	 FC	 pVAL	 FDR	
IFN-a	&	IFN-b	signaling	 	 	 Extracellular	matrix	 	 	 	
Ifit1	 7.4	 1.0E-05	 3.1E-03	 Chi3l1	 9.6	 1.0E-05	 3.1E-03	
Usp18	 7.2	 3.4E-06	 2.1E-03	 Cp	 8.5	 2.3E-04	 1.0E-02	
Mx2	 6.9	 5.2E-05	 5.3E-03	 Spon1	 6.9	 3.8E-05	 4.5E-03	
Sp100	 6.8	 6.5E-06	 2.9E-03	 Serpina3n	 5.5	 9.2E-05	 6.6E-03	
Ifi44	 6.7	 2.0E-06	 2.0E-03	 Scube2	 4.9	 1.7E-03	 2.9E-02	
Irf7	 6.1	 5.1E-05	 5.3E-03	 Pcdhac2	 4.5	 8.1E-04	 1.9E-02	
Iigp1	 6.1	 1.2E-06	 1.9E-03	 Has1	 4.5	 1.9E-05	 3.5E-03	
Oasl2	 5.7	 3.5E-06	 2.1E-03	 Pcolce2	 4.2	 2.7E-04	 1.1E-02	
Isg15	 4.1	 2.8E-04	 1.1E-02	 Adamtsl2	 3.7	 4.7E-04	 1.4E-02	
Oas2	 3.8	 1.9E-04	 9.4E-03	 Fn1	 3.1	 8.0E-04	 1.9E-02	
Ifih1	 3.8	 9.5E-06	 3.1E-03	 Eln	 2.5	 5.2E-03	 5.1E-02	
Isg20	 3.2	 2.0E-03	 3.1E-02	 Cell	adhesion	&	cell	junction	
Igtp	 3.0	 6.8E-05	 6.0E-03	 Dpt	 9.6	 4.0E-05	 4.7E-03	
Oasl1	 2.5	 2.7E-04	 1.1E-02	 Lgals3bp	 6.0	 8.9E-06	 3.1E-03	
Angiogenesis	/vascular	development	 	 Gsn	 4.1	 8.9E-05	 6.5E-03	
Ntrk2	 4.8	 7.9E-05	 6.3E-03	 Selp	 3.3	 1.6E-02	 9.6E-02	
Xdh	 4.2	 6.4E-05	 5.8E-03	 Spock2	 2.9	 7.2E-06	 2.9E-03	
Sema3c	 3.3	 5.0E-04	 1.5E-02	 Itgb3	 2.9	 7.9E-03	 6.5E-02	
Fgf1	 2.9	 2.8E-05	 3.8E-03	 Itga8	 2.7	 2.4E-03	 3.4E-02	
Pdpn	 2.8	 5.0E-04	 1.5E-02	 Itga2b	 2.7	 1.5E-02	 9.2E-02	
Vegfa	 2.7	 5.3E-05	 5.3E-03	 Itgb5	 2.7	 2.5E-04	 1.1E-02	
Srpx2	 2.7	 1.2E-03	 2.3E-02	 Itgb2	 2.7	 7.7E-03	 6.4E-02	
Fgfr4	 2.6	 5.3E-03	 5.2E-02	 Tgm1	 2.6	 6.3E-05	 5.8E-03	
Sphk1	 2.6	 2.1E-04	 9.8E-03	 Fermt3	 2.4	 3.3E-02	 1.4E-01	
Fgfr3	 2.5	 1.9E-03	 3.0E-02	 Npnt	 2.3	 1.1E-02	 7.8E-02	
Ang	 2.4	 2.8E-02	 1.3E-01	 Receptors	and	kinases	 	 	
Ccbe1	 2.4	 7.2E-05	 6.1E-03	 Ntrk2	 4.8	 7.9E-05	 6.3E-03	
Figf	 2.1	 3.2E-02	 1.4E-01	 Ccbp2	 3.8	 1.3E-03	 2.4E-02	
C7	 17.6	 3.7E-05	 4.5E-03	 Fgfr4	 2.6	 5.3E-03	 5.2E-02	
Hc	 8.1	 7.1E-06	 2.9E-03	 Sphk1	 2.6	 2.1E-04	 9.8E-03	
Serpine1	 5.0	 7.9E-05	 6.3E-03	 Fgfr3	 2.5	 1.9E-03	 3.0E-02	
Bdkrb2	 4.3	 7.8E-03	 6.4E-02	 Nrbp2	 2.4	 3.3E-04	 1.2E-02	
Serping1	 3.7	 5.7E-04	 1.6E-02	 Vipr2	 2.3	 1.2E-04	 7.1E-03	
Clec3b	 3.5	 7.1E-05	 6.1E-03	 S1pr3	 2.2	 3.3E-02	 1.4E-01	
F2rl2	 3.5	 5.8E-02	 1.9E-01	 Transcription	Factors	
Clec1b	 2.9	 6.9E-02	 2.1E-01	 Sp100	 6.8	 6.5E-06	 2.9E-03	
Cfh	 2.6	 5.6E-03	 5.4E-02	 Irf7	 6.1	 5.1E-05	 5.3E-03	
Tfpi2	 2.1	 4.4E-02	 1.6E-01	 Fhl5	 6.0	 4.1E-02	 1.6E-01	
Rsad2	 8.1	 4.7E-04	 1.5E-02	 Nfe2	 3.2	 9.2E-03	 7.0E-02	
Scd1	 6.6	 1.2E-07	 8.4E-04	 Ddx60	 3.2	 4.7E-03	 4.9E-02	
Hsd11b1	 4.3	 1.1E-03	 2.2E-02	 Tcf21	 3.2	 2.2E-02	 1.1E-01	
Olr1	 4.2	 9.7E-07	 1.9E-03	 Aff3	 3.1	 2.4E-05	 3.6E-03	
Ch25h	 3.6	 5.8E-03	 5.5E-02	 Daxx	 2.4	 4.9E-04	 1.5E-02	
Fabp4	 3.5	 4.0E-03	 4.4E-02	 	 	 	 	
 
 Table 1. Classification of genes upregulated in E18.5 vs. E16.5 PLECs   






FC	 Pval	 FDR	 		 FC	 Pval	 FDR	
Cell	Cycle	 		 		 		 mRNA	Processing	 		 		
Mcm5	 -4.1	 8.6E-05	 6.5E-03	 Tmem48	 -3.5	 5.2E-07	 1.8E-03	
Tipin	 -4.0	 1.6E-05	 3.5E-03	 Raet1d	 -3.4	 5.7E-03	 5.4E-02	
Fbxo5	 -3.8	 1.6E-04	 8.7E-03	 Rrm2	 -3.3	 2.5E-05	 3.6E-03	
Bub1	 -3.7	 5.1E-05	 5.3E-03	 Pmf1	 -3.2	 1.8E-05	 3.5E-03	
Kif11	 -3.4	 6.8E-05	 6.0E-03	 Exosc6	 -2.7	 5.6E-03	 5.3E-02	
Cenph	 -3.3	 1.1E-06	 1.9E-03	 Rnaseh2b	 -2.4	 1.7E-05	 3.5E-03	
Chek1	 -2.9	 3.5E-05	 4.4E-03	
	 	 	 	Mki67	 -2.4	 3.2E-03	 4.0E-02	 Ubiquitin	proteasome	pathway	 	
Iqgap3	 -2.0	 4.6E-03	 4.8E-02	 Dtl	 -3.3	 3.4E-06	 2.1E-03	
	 	 	 	
Skp2	 -3.1	 5.0E-05	 5.3E-03	
DNA	Replication	 	 	 Usp1	 -2.6	 2.3E-04	 1.0E-02	
Pole	 -4.4	 3.2E-05	 4.2E-03	 Uhrf1	 -2.5	 4.9E-04	 1.5E-02	
Rfc4	 -3.8	 4.8E-06	 2.4E-03	 Uchl5	 -2.3	 7.6E-04	 1.8E-02	
Rad51	 -3.4	 1.2E-04	 7.1E-03	 Ube2c	 -2.1	 1.9E-04	 9.4E-03	
Cenph	 -3.3	 1.1E-06	 1.9E-03	
	 	 	 	Dtl	 -3.3	 3.4E-06	 2.1E-03	 Transcriptional	regulators	 	 	
Chaf1b	 -3.2	 1.1E-04	 6.9E-03	 E2f8	 -3.6	 1.6E-04	 8.6E-03	
Lig1	 -3.2	 3.7E-06	 2.1E-03	 Tacc3	 -2.9	 2.3E-05	 3.6E-03	
	 	 	 	
E2f1	 -2.8	 7.8E-04	 1.8E-02	
Oxidoreductase	Activity	 	 	 Foxp2	 -2.7	 3.7E-02	 1.5E-01	
Cyp1a1	 -3.3	 6.3E-03	 5.7E-02	 Foxm1	 -2.6	 1.0E-04	 6.9E-03	
Dhfr	 -3.2	 2.2E-05	 3.5E-03	 Cdk4	 -2.4	 5.7E-04	 1.6E-02	
Mthfd2	 -2.3	 7.4E-04	 1.8E-02	 Rbl1	 -2.2	 7.8E-05	 6.3E-03	
Srd5a1	 -2.2	 1.9E-04	 9.4E-03	 Trp53	 -2.2	 1.0E-05	 3.1E-03	
Dhcr7	 -2.0	 2.5E-04	 1.1E-02	
	 	 	 	
	 	 	 	
Receptors	and	receptor	interactors	 	
Chromosome	maintenance	 	 Hmmr/Rhamm	 -3.0	 2.5E-04	 1.1E-02	
Hells	 -5.5	 3.5E-06	 2.1E-03	 Lpar4	 -2.7	 1.2E-04	 7.1E-03	
Prim1	 -4.9	 3.8E-06	 2.1E-03	 Trip13	 -2.3	 2.4E-03	 3.4E-02	
Mcm7	 -3.7	 3.7E-06	 2.1E-03	 Lpar6	 -2.2	 1.7E-03	 2.8E-02	
Smc2	 -3.6	 1.6E-04	 8.6E-03	 Traf4	 -2.0	 4.1E-03	 4.5E-02	
Mcm2	 -3.2	 2.6E-05	 3.7E-03	 Mc5r	 -2.0	 3.2E-02	 1.4E-01	
Dkc1	 -2.4	 2.8E-04	 1.1E-02	
	 	 	 	
	 	 	 	 	 	 	 	Cell	adhesion	&	cell	junction	 	
	 	 	 	Stab2	 -2.9	 2.2E-04	 1.0E-02	
	 	 	 	Cldn6	 -2.3	 1.3E-02	 8.7E-02	
	 	 	 	Vcan	 -2.3	 2.4E-02	 1.2E-01	
	 	 	 	Cdh2	 -2.1	 3.2E-04	 1.2E-02	
	 	 	 	 
Table 2. Classification of down-regulated genes in E18.5 vs. E16.5 PLECs		








Figure 1.7. Down-regulation of cell-cycle and upregulation of IFN 
pathway genes in fetal PLECs. RT-qPCR analysis of gene expression in 
independently sorted PLEC samples, (E16.5, n=3; E18.5, n=2 or n=3 for 
Ifit1 and Irf7).  Statistical analysis was performed using an unpaired 1-tailed 






The switch from placental to pulmonary gas exchange at birth requires fluid 
removal and the capacity to face the immunologic challenges of air breathing, 
and an intact and mature pulmonary lymphatic system is essential for each of 
these fundamental processes.  In this study we developed and implemented a 
cell sorting strategy that enabled the first transcriptional profiling of PLECs during 
late gestation. 
 
GSEA was used to identify pathways that are coordinately regulated from E16.5 
to E18.5.  This analysis demonstrated that genes involved in IFN signaling are a 
salient characteristic of maturing pulmonary lymphatics, which was confirmed by 
real-time qPCR and in situ hybridization. Transcriptional activation of IFN target 
genes at E18.5 indicates that PLECs act as a receiver of IFN signaling during 
late gestation.  Although the specific effects of IFN on lymphatic formation and 
function in the lung have not been definitively studied, the prevailing concept is 
that IFNs inhibit both angiogenesis and lymphangiogenesis in postnatal life 
(Chaitanya et al., 2010; Kataru et al., 2011; Shao and Liu, 2006; Zheng et al., 
2011) .  Others have linked IFNα signaling to fetal hematopoietic stem cell 
maturation (Kim et al., 2016).  Taken together, these findings are consistent with 
a role for IFN signaling in maturation of the pulmonary lymphatic endothelium 










Figure 1.8.  Increased expression of Ifit1 mRNA in E18.5 PLECs in vivo. 
Single molecule fluorescent in situ hybridization for Ifit1 mRNA (red punctae) and 
Vegfr3 (green) immunostaining in E16.5 and E18.5 lungs.  Boxed, numbered 
insets have been cropped, magnified and shown at the right of each image. Note 
the increased red punctae representing Ifit1 mRNA in Vegfr3+ PLECs at E18.5. 




Genes involved in angiogenesis were upregulated in PLECs from E16.5 to 
E18.5. One key example is sphingosine kinase 1 (Sphk1), which is required for 
the production of sphingosine-1-phosphate (S1P), a lipid important for 
angiogenesis, vascular maintenance, LEC maturation, as well as lymphocyte 
egress from lymphoid organs (Onder et al., 2017; Pham et al., 2010). Ccbe1 
which was upregulated in E18.5 PLECs, is a potentiator of Vegf-C and mutations 
in Ccbe1 result in lymphatic malformation, lymphedema and other complex 
phenotypes associated with Hennekam syndrome (Bos et al., 2011; Bui et al., 
2016; Hogan et al., 2009; Roukens et al., 2015).   
Genes involved in the complement and coagulation cascade were upregulated in 
E18.5 PLECs.  For proper interstitial fluid clearance and leukocyte trafficking, 
lymph must be a hypo-coagulable biological fluid (Le et al., 1998; Lippi et al., 
2012).  Consistent with this, we observed increased expression of anti-
coagulative genes (Serpine1 and Serping1), however genes known to promote 
coagulation (F2rl2, Tfpi2, and Clec1b/3b) were also induced in E18.5 PLECs. 
Coagulation and clot formation play an important role in lymphatic biology 
throughout life (Abtahian et al., 2003; Hess et al., 2014; Welsh et al., 2016), but a 
role for complement factors in lymphatic maturation and function has not been 
described.   
The lymphatic endothelium possesses several highly specialized features that 
make them unique and optimally adapted for clearance of interstitial fluids, 




contain incomplete basement membranes devoid of pericyte investment, and 
exhibit discontinuous intercellular junctions termed “button-junctions,” entry 
points for fluids, macromolecules and leukocytes (Baluk et al., 2007; Yao et al., 
2012).  Notably, our analysis identified a cluster of genes that are significantly 
upregulated at E18.5, which encode for proteins critical to cell adhesion, cell-cell 
junctions and interaction with the extracellular matrix.  This cluster also contains 
the surface receptor Fgfr3, a direct target of Prox1 (Shin et al., 2006), which is 
critical for lymphatic development, growth and regulation of LEC metabolism (Yu 
et al., 2017).  Other genes in this cluster include Ccbp2/D6, which is expressed 
by LECs to influence adaptive immunity (McKimmie et al., 2013).  Transcription 
factors such as Sp100, a tumor suppressor known to regulate endothelial 
migration and angiogenesis (Yordy et al., 2005); Trim30a, a TLR-responsive 
inhibitor of NF-kB signaling (Shi et al., 2008) and Irf7, the master regulator of 
IFN-I mediated immune protection (Honda et al., 2005) were upregulated in 
E18.5 PLECs. Further, Pdpn, required for proper lymphatic-venous separation 
during development and for dendritic cell migration to lymph nodes in postnatal 
life (Bianchi et al., 2017), and Sema3c, a member of the Semaphorin 3 family 
involved in lymphatic maturation and valve formation (Jurisic et al., 2012) were 
each upregulated at E18.5.  Furthermore, GSEA and cluster analyses showed 
down-regulation of genes involved in cell cycle regulation and DNA replication 
pathways, suggestive of cellular maturation or terminal differentiation of the 







Figure 1.9.  PLEC-specific transcriptional events during fetal lung maturation.  
Gene Set Enrichment Analysis (GSEA) demonstrated that genes annotated with 
the GO term "chemokine activity" (GO:0008009) (A) or NF-κB target genes 
(TRANSFAC motif V$NFKAPPAB_01) (B) were significantly (FDR q < 0.25) 
coordinately upregulated during fetal maturation in PLECs but not in whole lung 
(GEO Series GSE35485). Expression of the genes in the leading edge of each 
PLEC GSEA result is shown in both datasets, with red and blue indicating values 
up- or down-regulated, respectively, at least 3-fold from the mean (white) across all 
samples within each dataset (A-B). (C) The expression of select genes changes 
significantly (one-way ANOVA p < 0.05) with respect to time in sorted PLECs 





Lastly, recent evidence indicates a major role for fatty acid β-oxidation and lipid 
metabolism in lymphatic development (Wong et al., 2017). Our data are in line 
with these findings since the microarray analysis detected increased expression 
of genes involved in lipid biosynthesis and metabolism in E18.5 PLECs 
suggesting a link between lipid signaling and prenatal pulmonary lymphatic 
maturation.  
 
Gene sets such as “chemokine activity” and “NF-kB targets” were enriched 
specifically in E18.5 PLECs. It is noteworthy that genes with NF-kB binding sites 
in their promoters were enriched in PLECs during late fetal gestation because 
constitutive NF-kB activity has previously been shown in lymphatic beds of 
multiple organs in adult mice(Saban et al., 2004).  Both Cxcl1 and Cxcl10, ISGs 
which regulate chemotaxis and leukocyte trafficking (Card et al., 2014) were 
represented in both PLEC specific gene sets and in type-I IFN signaling. Other 
upregulated genes unique to PLECs were Ch25h and S1pr3.  Ch25h is involved 
in catabolism of cholesterol and leads to generation of oxysterol, a ligand for 
EBI2, a receptor that regulates chemotaxis and positioning of lymphoid lineages 
in lymph nodes (Yi et al., 2012). S1pr3, a gene upregulated specifically in PLECs 
promotes lymphoid mobilization from lymphoid tissues (Muppidi et al., 2015).  
Overall, our analyses identify broad mechanisms and PLEC specific signatures 





Chapter 1: CONCLUSIONS 
 
Overall, our microarray analysis indicated the repression and activation of 
multiple fundamental biological processes during the late-gestation development 
of PLECs and suggests the presence of a distinct prenatal maturation program 
for fetal PLECs.  Further studies are needed to determine the precise 
contribution of IFN signaling and other pathways to lymphatic maturation and 
postnatal pulmonary biology.  As these pathways may be involved in fetal lung 
lymphatic maturation and the successful transition to air breathing, our findings 












Previous work showed that myeloid-derived progenitors contribute to lymphatic 
and vascular endothelial cell populations in fetal life and after injury in adults.  
Whether similar processes occur as organs grow and mature after birth is not 
known. We interrogated whether myeloid cells contributed directly to lymphatic 
endothelial cells (LECs) in the post-natal lung.  We identified a CSF1R-lineage-
derived LEC progenitor that progressively replaces lineage negative LECs over-
time.  Induction of the CSF1R-lineage reporter at postnatal days (PND) 1-2 
labeled rare, single cells at PND 3 juxtaposed to lymphatic vessels that co-
expressed Prox1, a transcription factor required for LEC specification.  By PND 
30, nearly all LECs co-expressed the lineage tag and Prox1, and continued to be 
present in 8-month old mice.  This process was temporally restricted, as 
induction of the CSF1R-lineage tag during adulthood did not label LECs.  These 
results were further supported using other myeloid-Cre lineage tracing systems.  
In addition, selective Prox1 gene deletion in the CSF1R-lineage in early post-




findings show that early postnatal CSF1R-lineage progenitors contribute to the 
pulmonary lymphatic endothelium and that disruption of this process results in 
lymphatic hypoplasia/dysfunction.   
 
INTRODUCTION 
The lymphatic vasculature is composed of lymphatic endothelial cells (LECs) that 
coalesce into a branched hierarchy of small capillaries and larger collecting 
vessels that regulate interstitial fluids, lipid uptake and immunity.  These vessels 
drain protein-rich lymph from interstitial spaces, facilitate adaptive immunity and 
are specialized for organ-specific functions (Alitalo et al., 2005; Wiig et al., 2013; 
Zhang et al., 2018).  Numerous pathological conditions such as inflammation, 
lymphedema and cancer metastasis result from malformation, dysfunction, or 
cancer cell invasion of the lymphatic vasculature (Baluk et al., 2005; Karaman 
and Detmar, 2014; Rockson, 2001; Tammela and Alitalo, 2010).  
 
During development, LEC specification begins with Prox1 expression in a 
restricted subset of venous endothelial cells in the cardinal vein and other venous 
structures (Sabin, 1902; Srinivasan et al., 2007; Wigle and Oliver, 1999; Yang et 
al., 2012).  Prox1 induces a core set of lymphatic genes that lead to trans-
differentiation of venous endothelial cells into LEC progenitors.  LECs express 
Vegfr3, Lyve1 and Pdpn and migrate from venous lumens then coalesce to form 




established.  Subsets of LECs also arise from non-venous progenitors in multiple 
organs, though in this regard the lung has not been studied (Buttler et al., 2006; 
Huntington, 1910; Klotz et al., 2015; Martinez-Corral et al., 2015; Maruyama et 
al., 2005; Nicenboim et al., 2015; Pichol-Thievend et al., 2018; Stanczuk et al., 
2015).   
 
Interestingly, myeloid progenitors contribute to both blood endothelial and 
lymphatic endothelial cell populations during embryogenesis (Buttler et al., 2008; 
Klotz et al., 2015; Plein et al., 2018).  In adulthood, myeloid lineages may 
contribute to LECs after corneal injury in mice and kidney transplantation in 
humans (Kerjaschki et al., 2006; Maruyama et al., 2005), thereby raising the 
possibility that myeloid cells contribute directly to lymphangiogenesis in the 
postnatal lung.  
 
Myeloid cells are marked by expression of CSF1R (Colony-stimulating-factor-1 
receptor), a receptor that transmits signals required for their survival and 
differentiation (Wynn, 2013 #568; Chitu, 2017 #529}.   Based on this, myeloid 
lineages have been identified using transgenic mice that express a CSF1R 
promoter dependent Cre recombinase (CSF1R-CreER) that faithfully and 
specifically reflects endogenous CSF1R expression at the time of induction with 
tamoxifen (TAM) (Gomez Perdiguero et al., 2015; Mass et al., 2016; Qian et al., 





In this study, we performed a series of lineage tracing experiments which 
demonstrate that postnatal CSF1R+ progenitors contribute to the pulmonary 
lymphatic endothelium.  This process was temporally restricted since adult 
CSF1R+-lineages did not contribute to pulmonary LECs at steady state.  These 
findings were further confirmed using additional myeloid-related lineage tracing 
systems and by demonstrating lymphatic hypoplasia in lungs following genetic 
deletion of Prox1 in the CSF1R-lineage.  Taken together, these findings suggest 
a new paradigm whereby pulmonary LECs arise from CSF1R+ progenitors in the 





MATERIALS AND METHODS 
Mice  
Mice were obtained from Jackson labs: CSF1R-CreER (Qian et al., 2011), cat: 
019098; CSF1R-iCre (Deng et al., 2010) cat: 021024; Cx3cr1-Cre (Yona et al., 
2013) cat: 025524; Rosa-LSL-tdTomato(Madisen et al., 2010)) cat: 007914.  
Prox1-floxed mice were a generous gift from Dr. Guillermo Oliver (Harvey et al., 
2005).  Mouse lines for lineage tracing experiments were maintained on a mixed 
background.  CSF1R-CreER;Prox1-floxed mice were maintained on a mixed 
NMRI; FVB; C57BL/6 background.  Mice had access to water and standard 
murine chow ad libitum and were kept on a 12hr light-dark cycle. All mice were 
ethically euthanized under Isoflurane anesthesia followed by cervical dislocation 
according to Boston University IACUC protocol #14419.   
 
Tamoxifen (Sigma) was administered i.p at concentrations of 5 mg/40 g body 
weight (adults) and 75 µg/g body weight (pups). Genotyping was performed by 
direct tdTomato visualization in the skin or with probes recommended by Jackson 
Laboratory.  Prox1-floxed mice were genotyped using primers [5’:CTC-TGT-
GGA-AAG-GAC-TCC-GAA-TC-3’] and [5’:ACA-CTA-AAC-AAG-CAA-ATG-GAA-






Tissue collection and processing 
For paraffin embedding, tissues were harvested after perfusion with ice-cold 
HBSS through the right ventricle and drop-fixed in 4% paraformaldehyde 
overnight at 4°C.  Samples were dehydrated through increasing ethanol 
gradients and xylene before embedding in paraffin under vacuum at 60°C.  
Frozen sections were prepared by overnight cryopreservation through sequential 
exposure to 30% sucrose, 30% sucrose:OCT (1:1 ratio) before embedding in 
OCT and freezing on dry ice.   
 
Immunostaining  
Prior to immunostaining, sections were de-paraffinized, rehydrated and 
processed for antigen retrieval via the microwave method in citrate buffer (H-
3300, Vector Labs), washed in PBS and blocked for 1 hr in 0.1%Tween-20 in 
PBS and 5% normal donkey serum.  Antibodies used were: goat anti-Prox1 
(R&D, AF2727), rat anti-Vegfr3 (Novus, AFL4), rat anti-Lyve1 (Novus, ALY7), 
Alexa Fluor conjugated secondary antibodies used were: donkey anti-goat 
AlexaFluor647, donkey anti-rat AlexaFluor488, donkey anti-rat AlexaFluor594, 
donkey anti-rabbit AlexaFluor-594 (all from Invitrogen).  Maximum intensity 
projections of 8-10 µm z-stack images were acquired on a Zeiss LSM 710 NLO 










Prox1-Flox/Flox (controls, n=3) and CSF1R-CreER;Prox1-Flox/Flox (n=3) were 
injected with TAM on PND 1 and 2 and sacrificed on PND7 or PND30.  Paraffin 
embedded and sections were processed for immunohistochemistry with anti-
Vegfr3 antibody (AF743).  Regions of interests (ROI) encompassing the entire 
lung section (proximal to distal) were imaged.  Binary images were created for 
Vegfr3+ pixels that met thresholding criteria (Intensity: 0-88).  The total number of 
Vegfr3+ pixels per area were quantified using the Analyze Particles parameter 
Table 1. Antibody Information 
 
Antibody Dilution MFG. Catalog No. 
  RFP/tdTomato  1:1000   Rockland   600-401-379 
  Prox1   1:500 (young) 
 1:100 (adult) 
  R & D   AF2727 
  Vegfr3   1:500   R & D    AF743 
  Vegfr3 (AFL4)  1:100   eBioscience   14-59-88-85 
Lyve1  1:100 Novus NBP1-43411 
  Donkey anti-Rabbit 




  A-21207 
 
 Donkey anti-Goat   




 Donkey anti-Rat 





Donkey anti-Goat  








with Fiji software (2.0.0) The Vegfr3+ area fraction for each sample is plotted with 
the group mean ± standard deviation using GraphPad Prism software.   
 
RNA-Scope (in situ hybridization)  
Antigen retrieval was carried out on 8 µm lung sections (n=3 mice/time point) via 
the microwave method. All reagents for peroxidase quenching, protease 
digestion, washing, hybridization and transcript detection of “Mm_Csf1r” 
(ACDBio, Cat: 428191, Lot: 16279A) and “Cre” (ACDBio, Cat: 312281, Lot: 
17233A) were purchased from the manufacturer and used according to the 
recommendations for the RNA Scope method (ACDBio).  Pre-digestion of DNA 
was performed on tissue sections with RNase-free DNase (Qiagen, Cat: 79254) 
in DNase Buffer (30 mM Tris, pH 7.2; 4 mM MgCl2; 0.1 mM DTT) for 15 minutes 
at room temperature after target antigen retrieval.  This was necessary to 
eliminate hybridization with the transgenic Cre DNA insert.  Hybridized sections 
were washed and processed for immunostaining with Prox1 or Vegfr3 antibodies 
as described above. 
 
Imaging  
Maximum intensity projections of 10-20 µm z-stack images were acquired on a 
Zeiss LSM 710 NLO confocal microscope using the smart setup tool in 




CSF1R-CreERtdTomato tissues were harvested as stated previously, with perfusion 
through the right ventricle with ice-bold PBS (pH 7.4) and fixed at 4°C overnight 
in 4% paraformaldehyde.   
 
Statistical analysis 
One-way ANOVA was used to determined statistical significance for percentage 
of tdTomato+ Prox1+ LECs out of total LECs at three indicated time points in 
Figure 2 (n=3/time point).  Statistical significance for lymphatic quantification 
experiments was determined by Student’s t-Test (p<0.05), (n=3 mice/group) in 






Derivation of LECs from the CSF1R- lineage in the postnatal lung.  
We sought to determine whether myeloid lineages contribute directly to the 
lymphatic endothelium in the postnatal lung.  To do this, we utilized a transgenic 
mouse that expresses an inducible Cre-recombinase under the control of the 
CSF1R promoter and a recombinase-dependent fluorescent tdTomato reporter 
(CSF1R-CreERtdTomato) (Gomez Perdiguero et al., 2015; Hoeffel and Ginhoux, 
2018; Mass et al., 2016; Plein et al., 2018; Schulz et al., 2012).  After TAM 
administration at PND1 and 2, fate mapping of CSF1R-lineages in the PND 3 
lung revealed efficient labeling of the lung macrophage compartment consistent 
with previous studies (Kasaai et al., 2017; Perdiguero and Geissmann, 2016).  
LECs were identified by immunostaining for lymphatic markers: Prox1, Vegfr3 or 
Lyve1.  
 
Though lumenal Prox1+ LECs at PND 3 were tdTomato-negative (Fig 1A-C), we 
identified rare, single CSF1R-lineage positive and Prox-1 positive cells 
juxtaposed to lymphatics and in interstitial spaces (Fig 1D). These single 
Prox1+/tdTomato+ cells continued to be observed in the PND 5 lung parenchyma 
(Fig. 2A).  At this time point, however Prox1+ LECs lining small peripheral 
lymphatic capillaries were also found to be positive for the CSF1R-CreERtdTomato 






Figure 2.1. CSF1R-lineage contributes to Prox1+ LECs in the neonatal 
lung. Schematic of CSF1R-CreER lineage tracing (A).  Representative 
confocal z-stack of Prox1 (B), tdTomato expression (C) and the merged image 
(D) in the PND 3 lung after i.p. TAM administration at PND 1 and 2.  Note: 
Prox1+ LECs are CSF1R-lineage negative at PND 3 (B-D).  Rare, non-
lumenal cells expressed both Prox1 and tdTomato (E) as shown in the boxed 
regions (1, 2) and in corresponding ortho-slice insets (1’-1’’’) and (2’-2’’’). 




Progressive accumulation of CSF1R-lineage to pulmonary lymphatics  
We quantified the progressive accumulation of CSF1R-lineage progenitors into 
lumenal LECs at PND 3, PND 30 and 8 months (Fig 2C).  At PND 3, (12.3 ± 
2.7%) of Prox1+ LECs were tdTomato+. By PND 30, (94.6 ± 4.9%) of LECs were 
CSF1R-lineage derived.  Notably, lineage positive LECs labeled at PND 1-2 
persisted to at least 8 months of age (85.2 ± 15.5%) (Fig 2D).    
 
To determine whether CSF1R+ progenitors were active in the adult lung during 
steady-state, CSF1R-CreERtdTomato mice were injected at PND 28 and 29 and 
sacrificed at PND 30, or injected at PND 60 and 61 and sacrificed at 14 months. 
While we observed labeling of macrophages, there were no tdTomato+ LECs at 
either time point examined (Fig. 3A, B).  These data indicate that CSF1R is not 
expressed in adult LECs and that the CSF1R-lineage progenitor contribution to 








Figure 2.2.  Progressive accumulation of CSF1R+ progenitors into 
pulmonary lymphatic vessels. Confocal z-stacks showing 
Prox1+/tdTomato+ single cells in the lung interstitial space after TAM injection 
at PND 1 and 2 (A, arrows) or in small peripheral lymphatic capillaries (B, 
arrows) in the PND 5 CSF1R-CreERtdTomato lung.  Longitudinal lineage tracing 
from PND 1-2 indicated increased tdTomato+/Prox1+ LECs in lymphatics of 
PND 30 lungs (C, arrows) and in 8 month-old mice (D, arrows).  The 
percentage of LECs with tdTomato expression at PND 3, PND 30 and 8 
months (n=3 per time point; ANOVA, p<0.0001; Student t-Test, n.s., not 







Figure 2.3. Csf1r-lineage contribution to pulmonary lymphatics are 
temporally restricted.  Representative confocal z-stack micrographs of 
lungs from adult CSF1RCreER;tdTomato mice injected with TAM (5 mg/40 
g/body weight) at PND 28-29 and analyzed at PND 30, (n=3) (A) or twice 
at PND60-61 and analyzed at 14 months (B) for Prox1 and Vegfr3 (n=3).  
Note: TAM injection in adult CSF1R-CreERtdTomato mice labels 
macrophages (open arrows) but not LECs (solid arrows).  Scale bars: 50 








Figure 2.4.  The CSF1R gene locus is not active in pulmonary LECs.  
Confocal z-stacks of Prox1 (red) and GFP (green) immunostaining in PND 
1 and PND 3 lungs of CSF1R-GFP reporter mice, respectively (A, B).  
Bright-field micrograph of Csf1r mRNA (magenta) in-situ hybridization 
followed by immunohistochemistry for Prox1 (brown) in lungs of PND 1 (C) 
and PND 3 (D) mice.  Epifluorescence of Cre mRNA (red) in-situ 
hybridization followed by immunohistochemistry for Vegfr3 (green) in lungs 
of PND3 (E), and PND7 (F), CSF1R-CreERtdTomato mice injected with TAM 




Endogenous CSF1R and Cre are not detected in pulmonary lymphatic 
endothelium 
We next performed a series of studies to distinguish whether labeling of LECs is 
due to expression of CSF1R during TAM injection; or due to the contribution of a 
lineage positive progenitor.   To do this, we analyzed the lungs of PND 1 and 
PND 3 CSF1R-GFP reporter mice where GFP is under the direct control of the 
CSF1R gene locus.  As expected, cells with macrophage morphologies were 
GFP+ throughout the lung.  In contrast, Prox1+ LECs did not co-localize with 
GFP (Fig. 4A-B).  
We employed in situ hybridization to assess expression of the endogenous 
CSF1R gene in LECs at PND 1 and 3.  Although CSF1R mRNA was observed in 
cells in the interstitium and alveolar spaces, these experiments indicated that 
CSF1R mRNA was not expressed in LECs (Fig. 4C-D).  These findings are 
consistent with published work (Plein et al., 2018).  We also used in situ 
hybridization to confirm that Cre mRNA was not expressed in LECs at PND 3 or 
PND 7 (Fig. 4E-F). Taken together, these findings show that the endogenous 
CSF1R gene and Cre-recombinase are not active in LECs during the time of 
TAM injection.  
 
We also analyzed postnatal lungs of a transgenic reporter mouse where Cre 
recombinase is constitutively expressed under the control of the CSF1R 




labeling of lung cells with macrophage-like morphologies but no labeling of LECs 
at PND 1.  In contrast, ortho-slice analysis of confocal z-stacks in the PND 7 lung 
indicated the presence of Prox1+/Lyve1+ LECs that were positive for the 
constitutive CSF1R-lineage reporter (Fig 5).  Collectively, these data further 
confirm our lineage tracing data shown in Figures 1-2.  
 
CX3CR1-Cre labels a subset of postnatal LECs 
We utilized LysM-Cre and CX3CR1-Cre reporter mice since they have been also 
used to track myeloid lineages (Yona et al., 2013).  While we noted extensive 
labeling of macrophage and type II cell populations in the constitutive LysM-Cre 
reporter mouse, we did not observe lineage labeling of LECs (data not shown), 
suggesting that the LysM promoter is not expressed by LECs and that LECs in 
the lung do not arise from the LysM lineage.  In the constitutive CX3CR1-
CretdTomato reporter, we found that Prox1+/Vegfr3+ LECs were tdTomato negative 
at PND 1 (Fig. 6A-B); however, at PND 10 we identified Prox1+ LECs that were 
tdTomato+ LECs (Fig. 6D).  These findings lend additional support to the concept 







Figure 2.5.  Time dependent expression of lineage positive pulmonary 
LECs in CSF1R-iCre mice. Schematic of constitutive CSF1R-iCre lineage 
labeling (A).  Confocal z-stack image of PND 1 CSF1R-iCretdTomato lungs 
stained for Prox1 (green) and DAPI (blue).  The outer perimeter of Prox1+ 
lymphatic vessel in B (left panel) is indicated by dashed lines in (B, middle 
and right panels) (B).  Confocal z-stacks of tdTomato (C) Lyve1 (D), and 
Prox1 (E) immunostaining in constitutive CSF1R-iCre
tdTomato
 harvested on 
PND 7 (arrows; 1, 2, 3).  3-D ortho-slice analysis of Prox1+/Lyve1+/ 
tdTomato+ LECs indicated by numbered arrows (1-3) in C, D, E (F). Small 
arrows indicate macrophage-like cells in lung interstitium, Scale bar: 50 µm 









Figure 2.6. Time-dependent lineage labeling of LECs in the CX3CR1-Cre 
mice.  Schematic of constitutive CX3CR1-Cre recombination-dependent 
lineage tracing (A). Representative confocal z-stack image of a PND 1 lung 
section immuno-stained for Prox1, Vegfr3 , tdTomato and DAPI (B). The outer 
perimeter of lymphatic vessels from (B) indicated by dotted lines in the 
tdTomato channel (C) showing no lineage expression in LECs.  
Representative image from PND 10 CX3CR1-Cre
tdTomato lungs showing 





To further assess the contribution of CSF1R lineage-derived LEC progenitors to 
lymphatic development, we selectively deleted Prox1 after birth.  For this, 
CSF1RCreER/+;Prox1flox/flox  and Cre-negative Prox1-flox/flox mice, were 
injected with TAM at PND 1 and 2.  At PND 7, quantification of the area fraction 
occupied by Vegfr3+ lymphatics was reduced by 34.1 ± 6.1% (n=3, p=0.006) 
(Fig. 7B, C). 
 
Compared to Cre-negative, Prox1-flox/flox littermate controls, histologic 
examination of CSF1RCreER;Prox1-flox/flox lungs revealed edematous foci in 
the distal lung parenchyma and aberrant clot formation in the pulmonary 
vasculature (Fig. 8A-D).  These findings indicate that Prox1 is required for the 
CSF1R-progenitor contribution to post-natal lymphatics and disruption of this 







Figure 2.7. Conditional deletion of Prox1 in CSF1R lineage results in 
lymphatic hypoplasia. Schematic of conditional CSF1R deletion of Prox1 
(A).  Representative immunohistochemistry of Vegfr3 in PND 7 lungs of 
Prox1-flox/flox (control) and CSF1RCreER;Prox1-flox/flox mice after TAM 
administration on PND 1-2. Binary image masks were created after 
thresholding for Vegfr3 staining (B). Quantification of the area occupied by 
Vegfr3+ lymphatics in PND 7 lungs of Prox1-flox/flox (control) and 
CSF1RCreER;Prox1-flox/flox mice (C). Statistical significance was 








Figure 2.8. Prox1 deletion in the CSF1R-lineage results in edematous foci 
and clots in postnatal lungs. Representative bright-field micrographs of 
hematoxylin and eosin stained lung of Prox1-Flox/Flox (A,C) and 
CSF1RCreER;Prox1-flox/flox mice (B, D) at PND7 after tamoxifen 
administration on PND 1-2.  Note: edematous foci (B, arrows) and vascular clots 






Herein, we used fate-mapping strategies to identify a CSF1R+ progenitor that 
contributes to pulmonary LECs during early neonatal development.  This central 
observation was reinforced by experiments utilizing other myeloid specific Cre 
mice and by showing no evidence of CSF1R promoter activity or off-target 
expression of Cre-recombinase in early post-natal LECs (Fig 4).  These findings 
indicate the existence of an exogenous CSF1R-lineage-derived LEC progenitor 
that is active during the early neonatal period.  While our data indicate that this 
cell is of a myeloid lineage, we cannot rule out the possibility that CSF1R marks 
a non-myeloid lymphangioblast. 
 
The origin of the lymphatic endothelium has been debated for more than 100 
years and the consensus in the field is that LECs are derived from embryonic 
veins. Multiple studies, however, have indicated the existence of a myeloid 
progenitor for LECs (Buttler et al., 2008; Kerjaschki et al., 2006; Klotz et al., 
2015; Kubota et al., 2009; Maruyama et al., 2005; Volk-Draper et al., 2017). 
Recently, CSF1R+ erythro-myeloid progenitors (EMPs) were shown to contribute 
to endothelial subsets in multiple organs during embryonic development, though 





While limited, several studies point to post-natal changes in lymphatic structures 
during organ growth and maturation.  For example, development of highly 
specialized cell junctions between extra-pulmonary tracheal LECs occurs during 
post-natal life (Baluk et al., 2007; Gale et al., 2002).  In addition, meningeal 
lymphatics form during the postnatal period (Antila et al., 2017).  In this latter 
study, meningeal lymphatic formation was associated with the presence of 
Lyve1+/Prox1- macrophages that may influence lymphatic development through 
release of key modulatory ligands (Antila et al., 2017; Ivanov and Randolph, 
2017; Vaahtomeri et al., 2017). 
 
As discussed, CSF1R specifically marks myeloid lineages and is a major 
regulator of macrophage differentiation and survival (Wynn et al., 2013).  In the 
lung, macrophage populations are established by three successive 
developmental waves (Tan and Krasnow, 2016).  During the first week of post-
natal life, fetal liver derived monocytes migrate from the lung interstitium to take 
up residence in alveolar spaces (Guilliams et al., 2013; Murphy et al., 2008). 
These findings underscore the dynamic nature of myeloid lineages in the early 
post-natal lung and may be relevant to our observations. 
 
The specification and maintenance of LEC fate requires Prox1 (Johnson et al., 
2008; Srinivasan et al., 2014; Wigle and Oliver, 1999).  Consistent with this, 




development results in a drastic reduction of lymphatic formation, edema, 
hemorrhage and perinatal death (Klotz et al., 2015; Srinivasan et al., 2007).  Our 
results indicate that Prox1 is similarly required for CSF1R+ progenitor 
contribution to LECs in post-natal life.  Edematous foci and clotting in the 
pulmonary vasculature were observed in lungs after Prox1 deletion in CSF1R-
derived LECs.  We speculate these observations may relate, in part, to reduced 
interstitial fluid clearance with secondary effects on lung blood flow.  Interestingly, 
previous work showed that disruption of the lymphatic vasculature was 
associated with disseminated intravascular coagulation (Cueni et al., 2010). 
 
In summary, our data demonstrate the existence of a CSF1R+ progenitor that 
contributes to the pulmonary lymphatic endothelium in the early postnatal period. 
We found that this progenitor was restricted to early postnatal time points and is 





Chapter 2: CONCLUSION 
This work, presented herein, opens exciting new avenues for future research and 
deepens our understanding of the processes underlying lymphatic development 
and maturation within the perinatal lung.  During the perinatal period, mammals 
must be primed for the transition from placental to pulmonary gas exchange; 
from an aqueous, sterile intrauterine environment to an airy, non-sterile extra-
uterine existence.  To successfully navigate these transitions, the neonate 
requires a functional lung for breathing air as well as a functional lymphatic 
system for regulation of tissue fluid and immunity.   
 
Overall, our results highlight that LECs undergo dynamic transcriptional 
regulation during fetal gestation immediately prior to birth.  The aim of future 
studies will determine central pathway regulators and their role in fetal and 
postnatal lymphatic biology.   
 
We also identified a novel CSF1R-lineage derived progenitor of LECs, which 
adds to the concept that non-venous progenitors contribute to lymphatic 
development in the postnatal lung.  However many interesting questions remain 
which will propel further investigations into whether this process is truly organ-
specific, and whether CSF1R progenitors originate in the bone marrow or from 
mesenchymal progenitors in the distal lung.  In addition, what is the 




contribute to adult LECs after infection or injury?  Answers to these questions 
may provide new targets to inhibit or augment lymphangiogenesis for the 
treatment of pathologic conditions associated with defective lymphangiogenesis 
and may improve our ability to therapeutically derive functional LECs for 
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